The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000070.3(CAPN3):c.550del (p.Thr184fs)

CA220352

17621 (ClinVar)

Gene: CAPN3
Condition: autosomal recessive limb-girdle muscular dystrophy
Inheritance Mode: Autosomal recessive inheritance
UUID: 266d9a32-6af0-4d75-a5cd-deb6d7ab141e
Approved on: 2025-01-09
Published on: 2025-01-09

HGVS expressions

NM_000070.3:c.550delA
NM_000070.3:c.550del
NM_000070.3:c.549delA
NM_000070.3(CAPN3):c.550del (p.Thr184fs)
NC_000015.10:g.42387804del
CM000677.2:g.42387804del
NC_000015.9:g.42680002del
CM000677.1:g.42680002del
NC_000015.8:g.40467294del
NG_008660.1:g.44702del
ENST00000349748.8:c.550del
ENST00000357568.8:c.550del
ENST00000397163.8:c.550del
ENST00000466369.5:n.1059del
ENST00000483208.5:n.781del
ENST00000495723.1:n.781del
ENST00000549793.5:n.781del
ENST00000638141.2:n.565del
ENST00000673705.1:c.70+3252del
ENST00000318023.11:c.550del
ENST00000349748.7:c.550del
ENST00000357568.7:c.550del
ENST00000397163.7:c.550del
NM_000070.2:c.550del
NM_024344.1:c.550del
NM_173087.1:c.550del
NM_024344.2:c.550del
NM_173087.2:c.550del
More

Pathogenic

Met criteria codes 4
PM3 PVS1 PP1 PP4_Strong
Not Met criteria codes 1
PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Limb Girdle Muscular Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CAPN3 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Limb Girdle Muscular Dystrophy VCEP
The NM_000070.3: c.550del p.(Thr184ArgfsTer36) variant in CAPN3 is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 5/24, leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1). This variant is one of the most common disease-causing variants in CAPN3 reported in patients with Eastern European and Mediterranean ancestry (PMID: 25900067). It has been detected in at least 36 individuals with LGMD (PMID: 17236769, 17994539, 26404900, 30919934, 31788660, 17702496, 27142102). Of those individuals, at least 11 were compound heterozygous and 18 were homozygous (1.0 pt) (PM3). At least one patient with this variant displayed progressive limb girdle muscle weakness as well as absent expression of calpain-3, which is highly specific for CAPN3-related LGMD (PP4_Strong; PMID: 17236769). The variant has also been reported to segregate with LGMD in two affected family members from two families (PP1, capped with PP4_Strong; PMID: 30919934). The filtering allele frequency of the variant is 0.0005368 for European (non-Finnish) exome alleles in gnomAD v2.1.1 (the upper threshold of the 95% CI of 48/113726), which is greater than the LGMD VCEP threshold (<0.0001) for PM2_Supporting (criterion not met). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/09/2025): PVS1, PM3, PP4_Strong, PP1.
Met criteria codes
PM3
This variant is one of the most common disease-causing variants in CAPN3 among Eastern European and Mediterranean populations (PMID: 25900067). It has been detected in at least 36 individuals with LGMD (PMID: 17236769, 17994539, 26404900, 30919934, 31788660, 17702496, 27142102). Of those individuals, at least 11 were compound heterozygous and 18 were homozygous (1.0 pt, PMID) (PM3).
PVS1
The NM_000070.3: c.550delA p.(Thr184ArgfsTer36) variant in CAPN3 is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 5/24 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
PP1
The variant has also been reported to segregate with LGMD in two affected family members from two families (PP1; PMID: 30919934). (capped with PP4_Strong)
PP4_Strong
At least one patient with this variant displayed progressive limb girdle muscle weakness as well as absent expression of calpain-3, which is highly specific for CAPN3-related DYSF (PP4_Strong; PMID: 17236769).
Not Met criteria codes
PM2
The filtering allele frequency of the variant is 0.0005368 for European (non-Finnish) exome alleles in gnomAD v2.1.1 (the upper threshold of the 95% CI of 48/113726), which is greater than the LGMD VCEP threshold (<0.0001) for PM2_Supporting (criterion not met).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.